Drug & Medication Database

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Cranial Sacral Drops 5003

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: EASTERN OYSTER (.1 g/mL). Category: BLA.

Brands: Oyster

Brands: Crataegus

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Crataegus Combination 9220

Uses For the temporary relief of symptoms associated with mild digestive upset.

Brands: Unda 24

Circulatory disorders, low blood pressure.

Brands: D-44

Use: Temporary relief of headache.

Brands: Crataegus Onopordon

Indications & dosage: As advised by a homoeopathic physician.

Brands: Bm Crataegus Oxy

Use: Temporarily supports overall heart function and relieves minor sensations of irregular or weak pulse, chest discomfort, and fatigue. May assist with general circulatory support and maintaining vitality.*

Brands: Crataegus Oxy

Uses Helps to promote relaxation and temporarily relieve mild nervousness

Brands: Unda 219

Uses For the temporary relief of overall poor circulation symptoms.

Brands: Unda 248

OTC- Purpose

Brands: Barrier Repair Cream

Purpose Oral demulcent Cough suppressant/Oral anesthetic

Brands: Creamy Strawberry Flavor Cough Drop

Dosage form: POWDER. Active ingredients: CRENOLANIB BESYLATE (1 kg/kg). Category: BULK INGREDIENT.

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Creosote Combination 9254

Brands: Cresolum

Dosage form: PELLETS, COATED, EXTENDED RELEASE. Active ingredients: CARVEDILOL PHOSPHATE (1 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: PELLETS, COATED, EXTENDED RELEASE. Active ingredients: CARVEDILOL PHOSPHATE (1 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION CRENESSITY contains crinecerfont, a selective corticotropin-releasing factor type 1 receptor antagonist, present as crinecerfont free base, with the chemical name, 2-thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)- N -[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl- N -2-propyn-1-yl. Crinecerfont free base is the S-enantiomer with an enantiomeric excess of at least 99.7%.

Brands: Crenessity

11 DESCRIPTION EUCRISA contains 2% crisaborole (w/w) in a petrolatum-based, white to off-white ointment and is for topical use. The active ingredient, crisaborole, is a phosphodiesterase-4 (PDE-4) inhibitor. Crisaborole is described chemically as 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole. The empirical formula is C 14 H 10 BNO 3 and the molecular weight is 251.1 g/mol.

Brands: Eucrisa

11 DESCRIPTION Crizanlizumab-tmca is a P-selectin blocker humanized IgG2 kappa monoclonal antibody that binds to P-selectin. Crizanlizumab-tmca is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. It is composed of 2 heavy chains, each containing 448 amino acids, and 2 light chains each containing 218 amino acids, with a theoretical molecular weight of approximately 146 kDa.

Brands: Adakveo

11 DESCRIPTION Crizotinib is a kinase inhibitor. The molecular formula for crizotinib is C 21 H 22 Cl 2 FN 5 O and the molecular weight is 450.34 daltons. Crizotinib is described chemically as ( R )-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1 H -pyrazol-4-yl]pyridin-2-amine. The chemical structure of crizotinib is shown below: Crizotinib is a white to pale-yellow powder with a pKa of 9.4 (piperidinium cation) and 5.6 (pyridinium cation).

Brands: Xalkori

Uses Temporarily relieves discomfort associated with inadequate iron absorption, including occasional extreme tiredness and skin paleness.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.

Brands: Bestmade Natural Products Bm208

Brands: Crocus Sativus

Dosage form: POWDER. Active ingredients: POLYGALA SENEGA ROOT (10 [hp_M]/kg); QUININE SULFATE (10 [hp_M]/kg); SAFFRON (10 [hp_M]/kg); VERONICASTRUM VIRGINICUM ROOT (10 [hp_M]/kg). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: LIQUID. Active ingredients: POLYGALA SENEGA ROOT (9998 [kp_C]/L); QUININE SULFATE (9998 [kp_C]/L); SAFFRON (9998 [kp_C]/L); VERONICASTRUM VIRGINICUM ROOT (9998 [kp_C]/L). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION MYTESI (crofelemer) delayed-release tablets is an anti-diarrheal, enteric-coated drug product for oral administration. It contains 125 mg of crofelemer, a botanical drug substance that is derived from the red latex of Croton lechleri Müll. Arg. Crofelemer is an oligomeric proanthocyanidin mixture primarily composed of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, and (–)–epigallocatechin monomer units linked in random sequence, as represented below.

Brands: Mytesi

DESCRIPTION: Each 5 mL ampule of Cromolyn Sodium Oral Solution (Concentrate) contains 100 mg cromolyn sodium, USP, in purified water. Cromolyn sodium is a hygroscopic, white powder having little odor. It may leave a slightly bitter aftertaste. Cromolyn Sodium Oral Solution (Concentrate) is clear, colorless, and sterile. It is intended for oral use. Chemically, cromolyn sodium is disodium 5,5’-[(2-hydroxy-trimethylene) dioxy]bis[4-oxo-4H-1-benzopyran-2-carboxylate].

Brands: Cromolyn Sodium

DESCRIPTION The active ingredient of cromolyn sodium inhalation solution USP is cromolyn sodium, USP. It is an inhaled anti-inflammatory agent for the preventive management of asthma. Cromolyn sodium, USP is chemically designated as disodium 5,5'- [(2-hydroxytrimethylene)dioxy] bis [4-oxo-4H-1-benzopyran-2-carboxylate]. The molecular formula is C 23 H 14 Na 2 O 11 ; the molecular weight is 512.34. Cromolyn sodium, USP is a water-soluble, odorless, white, hydrated crystalline powder.

Brands: Cromolyn Sodium Inhalation Solution

Description The active ingredient of cromolyn sodium inhalation solution USP is cromolyn sodium, USP. It is an inhaled anti-inflammatory agent for the preventive management of asthma. Cromolyn sodium, USP is chemically designated as disodium 5,5'- [(2-hydroxytrimethylene)dioxy] bis [4-oxo-4H-1-benzopyran-2-carboxylate]. The molecular formula is C23H14Na2O11; the molecular weight is 512.34. Cromolyn sodium, USP is a water-soluble, odorless, white, hydrated crystalline powder.

Brands: Cromolyn Sodium Inhalation Solution